Clinical trials
Pelvic Organ Prolapse trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 5 |
| Terminated | 4 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coloplast A/S | 2 |
| Mount Sinai Hospital, Canada | 2 |
| University of British Columbia | 2 |
| University of Calgary | 2 |
| ASTORA Women's Health | 1 |
| Fraser Health | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Ottawa Hospital Research Institute | 1 |
| Sarah Wozney | 1 |
| Sunnybrook Health Sciences Centre | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pelvic Organ Prolapse | 18 |
| Pelvic Floor Disorders | 3 |
| Cystocele | 2 |
| Hernia | 2 |
| Pathological Conditions, Anatomical | 2 |
| Rectocele | 2 |
| Sexual Dysfunction, Physiological | 2 |
| Urinary Incontinence, Stress | 2 |
| Uterine Prolapse | 2 |
| Postoperative Pain | 1 |
Trials
Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.